NCT04154293View on ClinicalTrials.gov

A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

August 20, 2021

Study Completion Date

August 30, 2021

Conditions
Congenital Ichthyosis
Interventions
DRUG

Isotretinoin

Topical Isotretinoin ointment

OTHER

Vehicle

Topical Vehicle Ointment

Trial Locations (11)

3052

Murdoch Children's Research Institute, RCH, Melbourne

4101

Queensland Children's Hospital, Brisbane

19140

The Children's Hospital of Philadelphia, Philadelphia

45229

Cincinnati Children's Hospital, Cincinnati

46168

The Indiana Clinical Trials Center, Plainfield

55112

Minnesota Clinical Study Center, New Brighton

70005

Austin Institute for Clinical Research, Inc, Metairie

85006

Medical Dermatology Specialists, Phoenix

94304

Stanford University School of Medicine, Palo Alto

06510

Yale Center for Clinical Investigation, New Haven

NSW 2217

Premier Specialists, The church, Kogarah

All Listed Sponsors
lead

Timber Pharmaceuticals Inc.

INDUSTRY

NCT04154293 - A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis | Biotech Hunter | Biotech Hunter